MEDITE CANCER DIAGNOSTICS, INC. — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/9fdc676c-cd8f-4f69-994a-5b995d92d5d3/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2017 | $-6.5M | 2017-01-01 – 2017-12-31 | evidence 0001654954-18-005606 |
| FY 2016 | $-1.7M | 2016-01-01 – 2016-12-31 | evidence 0001654954-17-003300 |
| FY 2015 | $-599.0k | 2015-01-01 – 2015-12-31 | evidence 0001415889-16-005503 |
| FY 2014 | $-394.0k | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-029402 |
| FY 2013 | $294.0k | 2013-01-01 – 2013-12-31 | evidence 0001144204-15-029402 |
| FY 2012 | $-1.3M | 2012-01-01 – 2012-12-31 | evidence 0001144204-13-019354 |
| FY 2011 | $-2.6M | 2011-01-01 – 2011-12-31 | evidence 0001144204-12-021999 |
| FY 2010 | $-2.2M | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-021999 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
MEDITE CANCER DIAGNOSTICS, INC. — all facts · Revenue · Net Income